Skip to main content
Clinical Trials/NCT04302688
NCT04302688
Completed
Not Applicable

Accurate Classification System for Patients With COVID-19 Based on Prognostic Nomogram

Renmin Hospital of Wuhan University1 site in 1 country669 target enrollmentDecember 10, 2019
ConditionsPneumonitis

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pneumonitis
Sponsor
Renmin Hospital of Wuhan University
Enrollment
669
Locations
1
Primary Endpoint
survival status
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The COVID-19 has a clustering morbidity trend and older people with chronic diseases are more likely to die, such as chronic renal insufficiency and chronic cardiovascular disease. We set up a COVID-19 pneumonia grading scale. The COVID-19 score system was validated to predict the clinical outcome of a patient.

Detailed Description

1. First we collect the medical records, according to the time sequence, the patients were divided into two groups, one is the model group, and the other is the validate group. 2. Responsible for the risk factor of regression equation according to the model. The patients were divided into three groups according to their total score of risk responsibility. 3. Compared with SEPSIS and CURB-65 grading system with the grading system we established.

Registry
clinicaltrials.gov
Start Date
December 10, 2019
End Date
March 4, 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Gong Qiong

Professor

Renmin Hospital of Wuhan University

Eligibility Criteria

Inclusion Criteria

  • Patients with novel coronavirus pneumonia should be examined and diagnosed by CT and swab test of viral nucleic acid.

Exclusion Criteria

  • Patients who should have died during the course of the disease, but the cause of death was unrelated to viral pneumonia.
  • Suspected patient review refers to the negative nucleic acid test.

Outcomes

Primary Outcomes

survival status

Time Frame: 10 December 2019 to 10 February 2020

survival status as of February 24, 2020

Study Sites (1)

Loading locations...

Similar Trials